Yes, here is a link to the article titled below.....you made comments here about it at the time (congratulating Fortuno as he predicted that PR before announced, so your memory must have been influenced by the market reaction to these PRs, yawn and forget about it
:
CytoDyn Files an IND and a Phase 2 Protocol with the FDA for the Treatment of NASH with Leronlimab
https://www.cytodyn.com/newsroom/press-releas...th-the-fda
Please do your own due diligence. All my posts and comments are not to be considered investment advice.